Lewis W. Coleman, Director at Immune Design Corp. (IMDZ), bought 12,000 shares at $9.00 ($109K) on 2017-07-10, disclosed to the SEC on 2017-07-12.
Open-market purchase of $109k IMDZ by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.00 | 10,000 | $90K | 82.8% |
| 2 | $9.33 | 2,000 | $19K | 17.2% |
| Total | $9.05 avg | 12,000 | $109K | 100% |
| Filing → |
| IMDZ | BUY | 2017-07-10 | $74K | — | Filing → |
| IMDZ | SELL | 2016-12-27 | $62K | — | Filing → |
| IMDZ | BUY | 2016-09-20 | $250K | — | Filing → |